A clinical trial led by researchers at the Ca’ Granda Ospedale Maggiore Policlinico and the University of Milan found a probiotic mixture that significantly shortened fever duration in children with upper respiratory tract infections (URTIs). Children who received a probiotic mixture containing Bifidobacterium breve M-16V, Bifidobacterium lactis HN019, and Lactobacillus rhamnosus HN001 experienced a median fever reduction of two days compared to those given a placebo.
Leave A Comment